Evidence map›Paper›PMID 20510215›Full record

ArticleJournal of the American College of Cardiology2010

Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome.

Subha V Raman, Orlando P Simonetti, Marshall W Winner, Jennifer A Dickerson, Xin He, Ernest L Mazzaferri, Giuseppe Ambrosio

2 registry-linked trialsAbstract readComparative Study
In one paragraph

Article in Journal of the American College of Cardiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01311700 phase4completednot on this map

Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The ME"Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion" (METOCARD-CNIC): A Randomized, Controlled Parallel-group, Observer-blinded Clinical Trial of Early Pre-reperfusion Metoprolol Administration in ST-segment Elevation Myocardial infarctionTOCARD-CNIC Trial.

TypeinterventionalSponsorFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIRan2010 to 2017Enrolled221ConditionsMyocardial InfarctionArmsInjectable (i.v.) metoprolol tartrate (up to 15 mg).
NCT01931852 nacompletednot on this mapstarted 2013, after this paper: background citation

Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin

TypeinterventionalSponsorWake Forest University Health SciencesRan2013 to 2020Enrolled312ConditionsAcute Coronary Syndrome, Chest PainArmsCardiac MRI, ACC/AHA Guideline adherent care
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 121 citations in OpenAlex.

  1. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2020
    Guideline
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Clinical Importance of Myocardial TMagnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2021
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease.The international journal of cardiovascular imaging · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Chest pain: coronary CT in the ER.The British journal of radiology · 2016
    Review
  17. Improved quantitative myocardial TMagnetic resonance in medicine · 2015
    Article
  18. Article
  19. Impact of motion correction on reproducibility and spatial variability of quantitative myocardial T2 mapping.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2015
    Article
  20. Cardiac magnetic resonance in clinical cardiology.World journal of cardiology · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Subha V RamanOhio State University, Columbus, Ohio 43210, USA. raman.1@osu.edu
Orlando P Simonetti
Marshall W Winner
Jennifer A Dickerson
Xin He
Ernest L Mazzaferri
Giuseppe Ambrosio
The Ohio State University · USUniversity of Maryland, College Park · USUniversity of Perugia · IT

Funding

University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
NCRR NIH HHS UL1 RR025755
6 · The paper itself

Abstract

objectivesThe aim of this study was to define the prevalence and significance of myocardial edema in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS).

backgroundMost patients with NSTE-ACS undergo angiography, yet not all have obstructive coronary artery disease (CAD) requiring revascularization. Identifying patients with myocardium at risk could enhance the effectiveness of an early invasive strategy. Cardiac magnetic resonance (CMR) can demonstrate edematous myocardium subjected to ischemia but has not been used to evaluate NSTE-ACS patients.

methodsOne hundred consecutive patients with NSTE-ACS were prospectively enrolled to undergo 30-min CMR, including T2-weighted edema imaging and late gadolinium enhancement before coronary angiography. Clinical management including revascularization decision-making was performed without CMR results.

resultsOf 88 adequate CMR studies, 57 (64.8%) showed myocardial edema. Obstructive CAD requiring revascularization was present in 87.7% of edema-positive patients versus 25.8% of edema-negative patients (p < 0.001). By multiple logistic regression analysis after adjusting for late gadolinium enhancement, perfusion, and wall motion scores, TIMI risk score was not predictive of obstructive CAD. Conversely, an increase in T2 score by 1 U increased the odds of subsequent coronary revascularization by 5.70 times (95% confidence interval: 2.38 to 13.62, p < 0.001). Adjusting for peak troponin-I, patients with edema showed a higher hazard of a cardiovascular event or death within 6 months after NSTE-ACS compared with those without edema (hazard ratio: 4.47, 95% confidence interval: 1.00 to 20.03; p = 0.050).

conclusionsIn NSTE-ACS patients, rapid CMR identifies reversibly injured myocardium due to obstructive CAD and predicts worse outcomes. Identifying myocardium at risk may help direct appropriate patients toward early invasive management.

Indexed as

ElectrocardiographyAcute Coronary SyndromeAgedAngioplasty, Balloon, CoronaryCohort StudiesCoronary AngiographyEdemaFemaleFollow-Up StudiesGadoliniumHumansImage EnhancementMagnetic Resonance ImagingMaleMiddle AgedMyocardiumGadoliniumPlatelet Aggregation Inhibitors

Identifiers

PMID20510215
PMCPMC3675879
OpenAlexW2029948050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.